Search

everythinglearnresearchcommunity

for

Search:↓

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Neurosteroids help control dopamine responses in the brain.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

A new method was developed to make finasteride for treating hair loss.

Finasteride blocks progesterone's effect on absence seizures in rats.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Neurosteroids may help treat disorders with too much dopamine activity.

3α‐OH‐DHP is essential for reducing nerve activity related to blood pressure control during pregnancy.

Controlling transposable elements is crucial for successful tissue regeneration.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

Apremilast improved symptoms in patients with severe skin conditions.

Different mutations in the 5 alpha-reductase-2 gene were found in affected individuals in the Dominican Republic, suggesting no common ancestry.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Blocking mTORC1 reduces skin tumor growth in mice.

Tigason improved hair growth in a boy with monilethrix without side effects.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Reducing granulosa cell pyroptosis may improve oocyte maturation in PCOS.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

A man developed skin issues from cancer medication, which improved with specific treatments.